INTU vs PFE: Which Is the Better Buy?
Side-by-side comparison of Intuit Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
Intuit Inc. · Technology
$396.57
+45.0% upside to fair value
High Conviction
Grade A-
VS
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
QuantHub Verdict
INTU has more upside to fair value
(+45.0%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
INTU |
PFE |
| Current Price |
$396.57 |
$26.33 |
| Fair Value Estimate |
$575.03 |
$33.85 |
| Upside to Fair Value |
+45.0%
|
+28.6%
|
| Market Cap |
$110.4B |
$149.8B |
| Forward P/E |
19.5x
|
19.3x
|
| EV / EBITDA |
19.0x
|
12.9x
|
| Price / Sales |
5.9x
|
2.4x
|
| Price / FCF |
18.1x
|
16.5x
|
| Revenue Growth YoY |
+15.6%
|
-1.2%
|
| Gross Margin |
80.8%
|
70.3%
|
| Operating Margin |
26.1%
|
24.7%
|
| Return on Equity |
19.6%
|
8.7%
|
| Dividend Yield |
1.17% |
0% |
| FCF Yield |
5.51%
|
6.06%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Intuit is a near-monopoly financial operating system for 60+ million American households and small businesses. TurboTax handles 40%+ of US e-filed returns; QuickBooks is so deeply embedded in SMB workflows it has become the default accounting standard. The stock has fallen 51% from its 2025 high as markets price in AI disruption that has not materialized at scale and may not, since tax complexity…
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Accumulation Zones
| Metric |
INTU |
PFE |
| Zone Low |
$431.27 |
$25.39 |
| Zone High |
$488.78 |
$28.77 |
| In Buy Zone? |
Yes
|
Yes
|